Page last updated: 2024-09-05

2'-hydroxyflavanone and Carcinoma, Anaplastic

2'-hydroxyflavanone has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hofman, J; Malcekova, B; Novotna, E; Skarka, A; Wsol, V	1

Other Studies

1 other study(ies) available for 2'-hydroxyflavanone and Carcinoma, Anaplastic

Article	Year
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3. Toxicology and applied pharmacology, 2014, Aug-01, Volume: 278, Issue:3 Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Carcinoma; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Flavanones; Humans; Hydroxyprostaglandin Dehydrogenases; Idarubicin; Kinetics; Neoplasm Proteins; Oxidation-Reduction; Recombinant Proteins	2014

Article

Year

Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.

Toxicology and applied pharmacology, 2014, Aug-01, Volume: 278, Issue:3

Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Carcinoma; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Flavanones; Humans; Hydroxyprostaglandin Dehydrogenases; Idarubicin; Kinetics; Neoplasm Proteins; Oxidation-Reduction; Recombinant Proteins

2014